The transmission of direct-acting antiviral resistance-associated substitutions (RAS) could hamper hepatitis C virus (HCV) cure rates and elimination efforts. A phylogenetic analysis of 87 men who have sex with men recently infected with HCV genotype 1a placed one-third (28/87) in a large cluster, in which 96% harbored NS5A M28V RAS.
Keywords: HIV co-infected MSM; hepatitis C virus; phylogenetic analysis; resistant associated substitutions; the WHO 2030 elimination goals.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.